CSF Rhinorrhea After Endonasal Intervention to the Skull Base (CRANIAL) - Part 2: Impact of COVID-19.

Journal: World neurosurgery 2021;149():e1090-e1097

PMID: 33444833

Abstract

BACKGROUND

During the coronavirus disease 2019 (COVID-19) pandemic, concerns have been raised regarding the increased risk of perioperative mortality for patients with COVID-19, and the transmission risk to healthcare workers, especially during endonasal neurosurgical operations. The Pituitary Society has produced recommendations to guide management during this era. We sought to assess contemporary neurosurgical practice and the effects of COVID-19.

METHODS

A multicenter prospective observational cohort study was conducted at 12 tertiary neurosurgical units (United Kingdom and Ireland). Data were collected from March 23 to July 31, 2020, inclusive. The data points collected included patient demographics, preoperative COVID-19 test results, operative modifications, and 30-day COVID-19 infection rates.

RESULTS

A total of 124 patients were included. Of the 124 patients, 116 (94%) had undergone COVID-19 testing preoperatively (transsphenoidal approach, 97 of 105 [92%]; expanded endoscopic endonasal approach, 19 of 19 [100%]). One patient (1 of 116 [0.9%]) had tested positive for COVID-19 preoperatively, requiring a delay in surgery until the infection had been confirmed as resolved. Other than transient diabetes insipidus, no other complications were reported for this patient. All operating room staff had worn at least level 2 personal protective equipment. Adaptations to surgical techniques included minimizing drilling, draping modifications, and the use of a nasal iodine wash. At 30 days postoperatively, no evidence of COVID-19 infection (symptoms or positive formal testing results) were found in our cohort and no mortality had occurred.

CONCLUSIONS

Preoperative screening protocols and operative modifications have facilitated endonasal neurosurgery during the COVID-19 pandemic, with the Pituitary Society guidelines followed for most of these operations. We found no evidence of COVID-19 infection in our cohort and no mortality, supporting the use of risk mitigation strategies to continue endonasal neurosurgery in subsequent pandemic waves.

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Address: Medical Sciences Division, University of Oxford, Oxford, United Kingdom.; Wellcome/EPSRC Centre for Interventional and Surgical Sciences and National Hospital for Neurology and Neurosurgery, London, United Kingdom.; Wellcome/EPSRC Centre for Interventional and Surgical Sciences and National Hospital for Neurology and Neurosurgery, London, United Kingdom. Electronic address: [email protected].; School of Medicine, Cardiff University, Cardiff, United Kingdom.; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals Trust, Cambridge, United Kingdom.; Birmingham Medical School, University of Birmingham, Birmingham, United Kingdom.; Department of Ear, Nose, and Throat, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.; Department of Neurosurgery, Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, United Kingdom.; Department of Neurosurgery, The Walton Centre, Liverpool, United Kingdom.; Department of Neurosurgery, Royal Victoria Infirmary, Newcastle, United Kingdom.; Department of Neurosurgery, King's College Hospital, London, United Kingdom.; Department of Neurosurgery, Hurstwood Park Neurosciences Centre and Royal Sussex County Hospital, Haywards Heath, United Kingdom.; Department of Neurosurgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Department of Neurosurgery, Hull University Teaching Hospitals, Hull, United Kingdom.; Department of Neurosurgery, Ninewells Hospital, Dundee, United Kingdom.; Department of Ear, Nose, and Throat, Salford Royal NHS Foundation Trust, Salford, United Kingdom.; Department of Neurosurgery, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.; National Hospital for Neurology and Neurosurgery, London, United Kingdom.; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal Trust, Salford, United Kingdom.; Department of Neurosurgery, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.; Department of Ear, Nose, and Throat, Cambridge University Hospitals Trust, Cambridge, United Kingdom.; Department of Neurosurgery, Queen's Medical Centre Nottingham, Nottingham, United Kingdom.; Department of Ear, Nose, and Throat, Royal Victoria Hospital, Belfast, United Kingdom.; Department of Neurosurgery, University Hospital of Wales, Cardiff, United Kingdom.; Department of Neurosurgery, University Hospital Southampton, Southampton, United Kingdom.; Department of Neurosurgery, Royal Hallamshire Hospital & Sheffield Children's Hospital, Sheffield, United Kingdom.; Department of Neurosurgery, Royal Victoria Hospital, Belfast, United Kingdom.; Department of Neurosurgery, The Western General Hospital, Edinburgh, United Kingdom.; Department of Neurosurgery, National Neurosurgical Centre, Beaumont Hospital, Dublin, United Kingdom.; Department of Neurosurgery, Cork University Hospitals, Cork, United Kingdom.; Department of Ear, Nose, and Throat, Cork University Hospitals, Cork, United Kingdom.; Department of Ear, Nose, and Throat, National Neurosurgical Centre, Beaumont Hospital, Dublin, United Kingdom.; Department of Neurosurgery, St George's University Hospitals Trust, London, United Kingdom.; Department of Neurosurgery, Charing Cross Hospital, London, United Kingdom.; Department of Ear, Nose, and Throat, Sheffield Teaching Hospitals, Sheffield, United Kingdom.; Department of Neurosurgery, University Hospitals Plymouth, Plymouth, United Kingdom.; Department of Neurosurgery, Barts and The Royal London Hospital, London, United Kingdom.; Department of Neurosurgery, Barking, Havering and Redbridge University Hospitals, Romford, United Kingdom.; Department of Neurosurgery, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.; Department of Ear, Nose, and Throat, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.; Department of Ear, Nose, and Throat, Ninewells Hospital, Dundee, United Kingdom.; Department of Neurosurgery, Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom; (41)School of Medicine, Keele University, Stoke-on-Trent, United Kingdom.; Department of Ear, Nose, and Throat, University Hospital of Wales, Cardiff, United Kingdom.; Department of Neurosurgery, Southmead Hospital Bristol, Bristol, United Kingdom.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.